Tactile Systems Technology TCMD 深 沪
等待开盘 07-01 09:30:00 美东时间
29.78
-0.490
-1.62%
华盛通- 最 高30.10
- 今 开30.10
- 成交量 20.52万股
- 最 低 29.23
- 昨 收 30.27
- 总市值 67.17万
- 52周最高 37.77
- 市盈率 静 36.35
- 换手率 0.91%
- 52周最低 9.415
- 委 比 -46.16%
- 总股本 2.26万
- 历史最高 76.63
- 量 比 0.51
- 振 幅 2.87%
- 历史最低 6.28
- 每 手 1
- 风险率 7.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10 Stocks That Prove Good Beats Perfect
There is a line from Epictetus that I have thought about more times than I can count over thirty years of doing this work. He said, “Make the best use of what is in your power, and take the rest as it happens.” Most investors are waiting for perfect. They want every indicator green, every box checke...
06-27 05:20
Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy
Tactile Medical launched the next-generation AffloVest HFCWO therapy system, offering enhanced comfort, connectivity, and ease of use for patients with chronic respiratory conditions like cystic fibrosis and bronchiectasis. The system features a lighter, more adjustable vest, built-in Wi-Fi and Bluetooth, and a user-friendly controller, supporting long-term therapy adherence. Designed with input from patients, clinicians, and DME partners, the ne...
06-02 12:00
美股大行评级 | 英伟达绩后获11家大行集体上调目标价；劳氏、ELF、Intuit、VF等惨遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx药业"超配"评级，目标价从84美元升至96美元；Ascendiant Capital：维持Liqtech国际"买入"评级，目标价从4.3美元升至4.4美元
05-22 10:18
BTIG Reiterates Buy on Tactile Systems Tech, Maintains $40 Price Target
BTIG analyst Ryan Zimmerman reiterates Tactile Systems Tech (NASDAQ:TCMD) with a Buy and maintains $40 price target.
05-21 18:16
Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
Tactile Medical announced that its management will participate in the William Blair 46th Annual Growth Stock Conference in Chicago, IL, from June 2-4, 2026. Management will present on June 2 at 9:20 a.m. Central Time. A live audio webcast will be available on the Company's investor relations website, with an archive for replay post-conference. Tactile Medical focuses on developing at-home therapies for chronic conditions, collaborating with clini...
05-20 20:05
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
BTIG Maintains Buy on Tactile Systems Tech, Raises Price Target to $40
BTIG analyst Ryan Zimmerman maintains Tactile Systems Tech (NASDAQ:TCMD) with a Buy and raises the price target from $38 to $40.
05-05 18:09
电话会总结 ｜ Tactile Systems(TCMD)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Tactile Systems业绩会实录，以下是2026年第一季度财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 总营收7,530万美元，同比增长23% - 淋巴水肿业务营收6,220万美元，同比增长23% - 气道清理业务营收1,300万美元，同比增长22% **盈利能力：** - 毛利率76.5%，较去年同期74%提升250个基点 - GAAP营业亏损150万美元，较去年同期450万美元亏损大幅改善66% - 净亏损180万美元（每股亏损0.08美元），较去年同期300万美元亏损（每股亏损0.13美元）改善41% - 调整后
05-05 12:30
Full Transcript: Tactile Systems Tech Q1 2026 Earnings Call
Tactile Systems Tech (NASDAQ:TCMD) reported first-quarter financial results on ...
05-05 06:09
